Bruce Leuchter, M.D.
New York, New York, United States
3K followers
500+ connections
New York, New York, United States
3K followers
500+ connections
Activity
-
Meet the Neurvati and GRIN Therapeutics, Inc. team at the International League Against Epilepsy’s 15th European Epilepsy Congress as we present new…
Meet the Neurvati and GRIN Therapeutics, Inc. team at the International League Against Epilepsy’s 15th European Epilepsy Congress as we present new…
Liked by Bruce Leuchter, M.D.
-
At the International League Against Epilepsy’s 15th European Epilepsy Congress in Rome, Italy, from September 7 to 11, we will present new data from…
At the International League Against Epilepsy’s 15th European Epilepsy Congress in Rome, Italy, from September 7 to 11, we will present new data from…
Liked by Bruce Leuchter, M.D.
-
We’re proud to share this major milestone for patients that wouldn’t have been possible without the dedication of our team and collaborators.
We’re proud to share this major milestone for patients that wouldn’t have been possible without the dedication of our team and collaborators.
Liked by Bruce Leuchter, M.D.
Experience
Education
Licenses & Certifications
-
American Board of Psychiatry and Neurology
-
Issued -
Series 7, 63, 86, 87, 79, 24
Financial Industry Regulatory Authority (FINRA)
More activity by Bruce
-
Very nice Click Therapeutics shout out by CEO Sundar Pichai today on the earnings call!
Very nice Click Therapeutics shout out by CEO Sundar Pichai today on the earnings call!
Liked by Bruce Leuchter, M.D.
-
Tuberous sclerosis complex (#TSC) is a genetic disorder that causes tumors to form in many different organs, primarily in the brain, eyes, heart…
Tuberous sclerosis complex (#TSC) is a genetic disorder that causes tumors to form in many different organs, primarily in the brain, eyes, heart…
Liked by Bruce Leuchter, M.D.
-
The Specialised Healthcare Alliance (SHCA) has published a comprehensive new report assessing the challenges individuals encounter when seeking a…
The Specialised Healthcare Alliance (SHCA) has published a comprehensive new report assessing the challenges individuals encounter when seeking a…
Liked by Bruce Leuchter, M.D.
-
#DYK that focal cortical dysplasia (FCD) is classified into three main types: type I, type II, and type III, each with distinct features and…
#DYK that focal cortical dysplasia (FCD) is classified into three main types: type I, type II, and type III, each with distinct features and…
Liked by Bruce Leuchter, M.D.
-
Our team is excited to gather with colleagues and thought leaders to share data from our ongoing study in GRIN-related disorder. Our dedication to…
Our team is excited to gather with colleagues and thought leaders to share data from our ongoing study in GRIN-related disorder. Our dedication to…
Shared by Bruce Leuchter, M.D.
-
Tomorrow, #MyCompany is hosting the first in what is sure to be a compelling webinar series called “Innovation Ignited.” My colleagues Fiona Elwood…
Tomorrow, #MyCompany is hosting the first in what is sure to be a compelling webinar series called “Innovation Ignited.” My colleagues Fiona Elwood…
Liked by Bruce Leuchter, M.D.
-
We’re thrilled and honored to be included in the Fierce Biotech 15 list for 2024! This recognition is a testament to our team’s hard work and…
We’re thrilled and honored to be included in the Fierce Biotech 15 list for 2024! This recognition is a testament to our team’s hard work and…
Liked by Bruce Leuchter, M.D.
-
I’m excited to share the official launch of ATP (Apple Tree Partners)’s newest company, Red Queen Therapeutics, to address both seasonal and…
I’m excited to share the official launch of ATP (Apple Tree Partners)’s newest company, Red Queen Therapeutics, to address both seasonal and…
Liked by Bruce Leuchter, M.D.
-
NEWS: The FOXG1 Research Foundation partners with Charles River Laboratories to advance its gene therapy program for FOXG1 syndrome. “We are…
NEWS: The FOXG1 Research Foundation partners with Charles River Laboratories to advance its gene therapy program for FOXG1 syndrome. “We are…
Liked by Bruce Leuchter, M.D.
-
Today, the CureGRIN Foundation will convene scientists and clinicians globally for the GRI Genes Research Roundtable, a forum to discuss the latest…
Today, the CureGRIN Foundation will convene scientists and clinicians globally for the GRI Genes Research Roundtable, a forum to discuss the latest…
Liked by Bruce Leuchter, M.D.
-
Last week we had the incredible opportunity to attend and speak at CureGRIN Foundation’s #MeetandGRI in London. It was a pleasure to meet the…
Last week we had the incredible opportunity to attend and speak at CureGRIN Foundation’s #MeetandGRI in London. It was a pleasure to meet the…
Liked by Bruce Leuchter, M.D.
-
The TSC Alliance recently announced the establishment of the Steven Sparagana Legacy Fund, dedicated to supporting the Natural History Database and…
The TSC Alliance recently announced the establishment of the Steven Sparagana Legacy Fund, dedicated to supporting the Natural History Database and…
Liked by Bruce Leuchter, M.D.
-
During GRIN2B Foundation's Family and Research Weekend, our Director of Community Engagement and Communication, Hillary Savoie, Ph.D., will discuss…
During GRIN2B Foundation's Family and Research Weekend, our Director of Community Engagement and Communication, Hillary Savoie, Ph.D., will discuss…
Liked by Bruce Leuchter, M.D.
-
This past weekend, our team had the opportunity to engage with clinicians, researchers, patients and community members during GRIN2B Foundation's…
This past weekend, our team had the opportunity to engage with clinicians, researchers, patients and community members during GRIN2B Foundation's…
Liked by Bruce Leuchter, M.D.
-
Today kicks off GRIN2B Foundation's Family and Research Weekend! This event will bring together researchers, clinicians, families, and patients to…
Today kicks off GRIN2B Foundation's Family and Research Weekend! This event will bring together researchers, clinicians, families, and patients to…
Liked by Bruce Leuchter, M.D.
-
Our recent survey on the impact of the US BIOSECURE Act. https://lnkd.in/eXdXKpit
Our recent survey on the impact of the US BIOSECURE Act. https://lnkd.in/eXdXKpit
Liked by Bruce Leuchter, M.D.
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More